These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6040308)

  • 1. [Niamid in treatment of coronary disease].
    Chojnowski JR; Chojnowska-Jezierska J; Adamska-Marcinkowska H
    Wiad Lek; 1967 Feb; 20(3):235-8. PubMed ID: 6040308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Niamid in the treatment of coronary insufficiency].
    Król W; Wójcikiewicz O
    Pol Tyg Lek; 1965 Apr; 20(17):608-11. PubMed ID: 5837304
    [No Abstract]   [Full Text] [Related]  

  • 3. [On high-dosage parenteral niamid treatment of depressive syndromes].
    Cornu F; Hodel J
    Nervenarzt; 1965 Dec; 36(12):515-8. PubMed ID: 5334474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nuredal in the treatment of ischemic heart disease].
    Raiskií VA; Kasatkina LV; Grigor'iants RA; Livshits NIa
    Kardiologiia; 1977 Mar; 17(3):137-8. PubMed ID: 886687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of niamide on atherosclerosis patients with predominantly coronary lesions].
    Ivanchenko FT; Kovaleva NI
    Vrach Delo; 1965 Jan; 1():63-7. PubMed ID: 5853995
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of niamide in coronary disease].
    Markiewicz M
    Pol Tyg Lek; 1969 Jul; 24(29):1129-31. PubMed ID: 4897262
    [No Abstract]   [Full Text] [Related]  

  • 7. The protective effect of niamid on hearing in patients treated with large doses of streptomycin.
    Semczuk B; Klonowski S; Golabek W
    Ann Univ Mariae Curie Sklodowska Med; 1974; 29():193-7. PubMed ID: 4467804
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of depressive conditions using nialamide infusions].
    Misurec J; Bojanovský J; Chloupková K
    Cesk Psychiatr; 1966 Apr; 62(2):114-8. PubMed ID: 5930847
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of depressive states with infusions of Nialamide.
    Misurec J; Bojanovský J; Chloupková K
    Act Nerv Super (Praha); 1965 Aug; 7(3):294-5. PubMed ID: 5883125
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroconvulsive therapy combined with Nialamide in treatment of depression.
    Misurec J; Jaros M
    Act Nerv Super (Praha); 1965 Aug; 7(3):293-4. PubMed ID: 5882127
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for a monoamine oxidase inhibitor hydrazine (nialamide) in the treatment of asthenic and hypochondriac neuroses. (Apropos of 70 ambulatory treatments)].
    Leyrie J
    Ann Med Psychol (Paris); 1965 May; 123(5):745-9. PubMed ID: 5834684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analgesic and antidepressive: nialamide in cancerology. Value of parenteral administration].
    Proux C; Toubiana CG
    Clinique (Paris); 1965 May; 60(607):388-91. PubMed ID: 5833447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of neuropton (nialamide-hydroxyzine pamoate)].
    Bourgeois M
    Ann Med Psychol (Paris); 1970 Jan; 1(1):134-8. PubMed ID: 5421306
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nialamide as a major antidepressive and anxiolytic agent].
    Dubois JC; Dacharry JC; Demoures JM
    J Med Bord; 1967 Oct; 144(10):1536-43. PubMed ID: 5605728
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychic and motor functions and serotonin (5 HT) metabolism in brain-damaged children before and after administration of Niamid and Raupasil.
    Madej A; Pakszys W
    Pol Med J; 1967; 6(5):1292-7. PubMed ID: 6080884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nialamide and the 8th nerve in the aged].
    Esteban F; Alí R
    Acta Otorinolaryngol Iber Am; 1966; 17(3):255-62. PubMed ID: 5946951
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychic and motor functions and serotonin (5-HT) metabolism in encephalopathic children prior to and following administration of niamid and raupasil].
    Madej A; Pakszys W
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1123-8. PubMed ID: 5993461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the use of a benzofuran derivative in the treatment of coronary cardiopathy].
    Taddeucci E; Terreni F
    Clin Ter; 1971 Apr; 57(2):163-9. PubMed ID: 5110941
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Serpasil, Niamid and Deseril on the excretion of 5-hydroxyindoloacetic acid in diurnal urine and on oxidase activity of ceruloplasmin in human serum.
    Pokora J
    Pol Med J; 1966; 5(3):716-22. PubMed ID: 5920288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.